Financials
- Market Capitalization 511.89 M
- Employee 353
- Founded 2012
- CEO David Moatazedi
- Website www.evolus.com
- Headquarter Delaware, United States
- FIGI BBG005CX4HK8
- Industry 医薬品メーカー(特殊・ジェネリック)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-8.31
売上高対価格比率
1.44
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2718 | IRWD Ironwood Pharmaceuticals, Inc. - Class A Common Stock | 3.76 USD | -1.57% | +3.30% | -8.29% | +129.27% | 621.30 M USD | ||
| 2733 | AQST Aquestive Therapeutics, Inc. - Common Stock | 4.81 USD | +0.63% | +4.11% | +2.34% | -27.01% | 603.71 M USD | ||
| 2850 | TLRY Tilray Brands, Inc. - Common Stock | 3.36 USD | -5.08% | -10.16% | -15.79% | +84.62% | 496.57 M USD | ||
| 2872 | EVO Evotec SE - American Depositary Shares each representing 1/2 of | 1.37 USD | -10.46% | -20.81% | -18.45% | -67.92% | 487.11 M USD |